Hytera Introduces Smart PoC Radios P50E and P60 at PMRExpo 2025
27.11.2025 09:00:00 CET | Business Wire | Press Release
Hytera, a leading global provider of critical communications technologies and solutions, has officially launched its latest smart Push-to-Talk over Cellular (PoC) radios – the P50E and the P60 – at PMRExpo 2025. This launch marks a significant expansion of Hytera’s PoC portfolio, delivering the company’s most robust and comprehensive range of devices to date, offering a wide spectrum of options to meet the growing demand for PoC solutions across all sectors throughout Europe.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251126296378/en/
Hytera unveiled new PoC radios P50E & P60 at PMRExpo 2025.
Stay Smart and Safe with the P50E
Featuring a compact 0.96-inch screen and a keyboard-free design, the P50E embodies the design philosophy of the P5 Series – Where Reliability Meets Simplicity. With the addition of the P50E, the P5 Series – which also includes the P50 and the P50 Pro – now provides users greater flexibility to align their product selection with specific application scenarios, customized solutions, and procurement budgets.
The P50E simplifies patrol operations with built-in NFC, allowing fast and accurate check-ins. Integrated with the Hytera HyTalk platform, the P50E enables teams to log routes, verify checkpoints, and receive real-time task updates – making it an ideal solution for Private Security and Property Management sectors.
Safety is central to the P50E. Equipped with lone worker and man down functions, the P50E provides automated monitoring for personnel working alone or in high-risk environments, triggering immediate alerts during emergencies or periods of inactivity.
Stay Intelligent and Reliable with the P60
Combining intelligence, dependability, and a rugged build, the P60 delivers smarter and more resilient connectivity for professionals in public safety, security, utilities, and transportation.
Built to Mission Critical Services (MCX) standards, the P60 ensures prioritized voice, video, and data transmission with ultra-low latency. It supports dual nano-SIM, eSIM, and WLAN connectivity to maintain call continuity, while intelligent network switching automatically selects the strongest available signal for uninterrupted communication.
In case of any emergency, the P60 also functions as a professional recording tool for on-site documentation. A simple slide across its 3.5-inch high-brightness touchscreen activates the 50MP rear camera, while simultaneously triggering 120-second pre-recording, ensuring no critical moment is missed. All captured photos and videos can be fully uploaded to the Hytera Digital Evidence Management (DEM) platform for centralized review and secure archiving.
“With the rapid development and large-scale adoption of broadband networks, Europe’s PoC market is experiencing robust growth. We are seeing increasing demand for PoC products and solutions from frontline markets,” said Sophia Yin, General Manager of Hytera Europe. “At this year’s PMRExpo, we showcased our most complete PoC portfolio to date, ranging from PoC to MCX product lines. This demonstrates Hytera’s significant investments and achievements in the field of broadband products.”
HALO PTX, a fully managed Push-to-Talk communications service with real-time data and video management, was highlighted with an outstanding design at the main corner of the booth drawing much attention during the exhibition. Requiring minimal upfront capital investment, HALO PTX enables partners to serve customers quickly and easily—without the need for servers, hosting, or data SIMs. It offers a predictable, ongoing revenue model, making it an attractive solution for partners seeking simplicity and scalability.
Hytera also showcased its recently released MCX device PNC660 450MHz, along with Fast Deployment solutions, BodyCam solutions, Retail solutions, HySEIS solutions, Airport solutions, and Energy solutions.
“We’ve never presented such a diverse range of exhibits at PMRExpo before. This is our direct response to the growing demands from customers across Emergency Response, Utilities, Oil & Gas, Retail, Hospitality, Private Security, and more,” added Sophia Yin. “I look forward to meeting our partners and customers at the booth to explore how we can further support their business growth.”
Visit Hytera at PMRExpo 2025
Hytera is exhibiting these products and solutions at PMRExpo 2025, Booth C36-D39, Hall 7, from November 25th to 27th.
About Hytera
Hytera Communications Corporation Limited (SZSE: 002583) is a leading global provider of critical communications technologies and solutions. Hytera has been serving worldwide users over three decades with its innovative portfolio of two-way radios, PMR<E convergent communications, fast-deploy communications, body-worn camera, control room, etc. Learn more at https://www.hytera.com/en/.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251126296378/en/
Contacts
lele.yao@hytera.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to disease biology is translating into meaningful clinical progress. Our GPC3 x 4-1BB bispecific antibody continues to be well tolerated and demonstrates durable activity with longer follow up in patients with heavily pre-treated hepatocellular carcinoma, while the first clinical data from our brain-penetrant PRMT5 inhibitor and CEA-targeting ADC expand our innovation in non-small cell lung cancer. Alongsi
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press Release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Society of Nephrology (ASN) Kidney Week 2026 in Denver, Colorado, and advancement of the povetacicept clinical research program in IgAN. Vertex will also host an investor event during ASN on October 23 at 6:15-7 p.m. MDT (8:15-9 p.m. EDT). Further details are below. Data being presented include a pre-specified Week 36 interim analysis of the ongoing Phase 3 RAINIER trial of povetacicept, an engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in immunoglobulin A nephropathy (IgAN). RAINIER met its primary endpoint, with povetacicept achieving a 52.0% reduction from baseline in proteinuria at Week 36 and a statistically significant and clinically meaningful 49.8% reduction versus placebo (
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:19:00 CEST | Press Release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “Following the U.S. approval in August, these longer-term data provide further evidence supporting TEVIMBRA plus ZIIHERA and chemotherapy as the new standard of care in all first-line HER2-positive advanced gastroesophageal adenocarcinoma patients, regardless of PD-L1 sta
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press Release
inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a leading Central Asian economy, this gives the companies a clear basis to assess autonomous ride-hailing in practice. The three companies will evaluate the technical, operational, regulatory and
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom